Article
GSTO1 as a Potential Risk Factor for Diabetic Nephropathy: Evidence From Mendelian Randomisation and Multi-Omics Analyses.
Nephrology (Carlton, Vic.) - 1 Jan 2026
Tan Jiang, Lei Sisi, Zhao Liang, Hu Jiliang, Chen Yuqin
Abstract excerpt
AIM: Diabetic nephropathy (DN) is a major complication of diabetes mellitus and a leading cause of end-stage renal disease (ESRD). Glutathione S-transferase omega 1 (GSTO1) is implicated in redox regulation and inflammation, but its causal role in DN remains unclear. This study aimed to investigate the potential causal relationship between GSTO1 and DN risk. METHODS: Two-sample Mendelian randomisation (MR)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
